(Q37928596)

25 August 2017

1 reference

title

Treatment-resistant depression in adolescents: review and updates on clinical management (English)

1 reference

treatment-resistant depression

25 August 2017

1 reference

1 reference

1

Fadi T Maalouf

1 reference

25 August 2017

2

Mia Atwi

1 reference

25 August 2017

David A Brent

3

1 reference

25 August 2017

language of work or name

1 reference

2 September 2011

1 reference

25 August 2017

published in

Depression and Anxiety

1 reference

25 August 2017

volume

28

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

946-954

1 reference

Practice parameter for the assessment and treatment of children and adolescents with depressive disorders

25 August 2017

cites work

1 reference

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Treatment-resistant depression in adolescents: recognition and management

21 January 2018

1 reference

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up

21 January 2018

1 reference

Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes

21 January 2018

1 reference

Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes

21 January 2018

1 reference

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

21 January 2018

1 reference

Treated depression in adolescents: predictors of outcome at 28 weeks

21 January 2018

1 reference

Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications.

21 January 2018

1 reference

The symptomatic expression of major depressive disorder in adolescents and young adults

21 January 2018

1 reference

Fluoxetine in child and adolescent depression: acute and maintenance treatment.

21 January 2018

1 reference

Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study

21 January 2018

1 reference

Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression

21 January 2018

1 reference

Substance use and the treatment of resistant depression in adolescents

21 January 2018

1 reference

Cross-sectional and prospective relationships between physical morbidity and depression in older adolescents

21 January 2018

1 reference

Psychiatric disorder and metabolic control among youths with IDDM. A longitudinal study.

21 January 2018

1 reference

The role of pharmacogenetics in the treatment of depression and anxiety disorders

21 January 2018

1 reference

Pharmacogenomics with antidepressants in the STAR*D study

21 January 2018

1 reference

Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study

21 January 2018

1 reference

Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders

21 January 2018

1 reference

Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study

21 January 2018

1 reference

Family risk factors for child and adolescent suicidal behavior

21 January 2018

1 reference

An exploratory analysis of the impact of family functioning on treatment for depression in adolescents

21 January 2018

1 reference

Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study

21 January 2018

1 reference

Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment

21 January 2018

1 reference

Remissions in maternal depression and child psychopathology: a STAR*D-child report.

21 January 2018

1 reference

Development of the cerebral cortex: XI. Sexual dimorphism in the brain

21 January 2018

1 reference

Age effects on antidepressant-induced manic conversion

21 January 2018

1 reference

Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings

21 January 2018

1 reference

Effects of psychotherapy for depression in children and adolescents: what we can (and can't) learn from meta-analysis and component profiling

21 January 2018

1 reference

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

21 January 2018

1 reference

Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine

21 January 2018

1 reference

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).

21 January 2018

1 reference

Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).

21 January 2018

1 reference

Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis

21 January 2018

1 reference

Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial

21 January 2018

1 reference

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

21 January 2018

1 reference

Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.

21 January 2018

1 reference

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

21 January 2018

1 reference

The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine

21 January 2018

1 reference

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

21 January 2018

1 reference

Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series

21 January 2018

1 reference

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

21 January 2018

1 reference

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression

21 January 2018

1 reference

Open Trial of Bupropion SR in Adolescent Major Depression

21 January 2018

1 reference

Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression

21 January 2018

1 reference

Practice parameter for use of electroconvulsive therapy with adolescents

21 January 2018

1 reference

Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy

21 January 2018

1 reference

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

21 January 2018

1 reference

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

21 January 2018

1 reference

Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression.

21 January 2018

1 reference

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study.

21 January 2018

1 reference

Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder

21 January 2018

1 reference

Neurocognitive impairment in adolescent major depressive disorder: state vs. trait illness markers

21 January 2018

1 reference

Cingulate function in depression: a potential predictor of treatment response.

21 January 2018

1 reference

Suicidal events in the Treatment for Adolescents With Depression Study (TADS).

21 January 2018

1 reference

Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT).

21 January 2018

1 reference

Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability

21 January 2018

1 reference

Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial

21 January 2018

1 reference

Half a century of ECT use in young people

21 January 2018

1 reference

Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report

21 January 2018

1 reference

Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children

21 January 2018

1 reference

7 January 2021

Antidepressants and adolescents: the bipolar confound?

1 reference

7 January 2021

Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation

1 reference

7 January 2021

Lithium Antidepressant Augmentation in TCA-refractory Depression in Adolescents

1 reference

7 January 2021

Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder

1 reference

7 January 2021

Executive dysfunction predicts nonresponse to fluoxetine in major depression

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20884

1 reference

25 August 2017

1 reference